Targeting NKG2D ligands in glioblastoma with a bispecific T-cell engager is augmented with conventional therapy and enhances oncolytic virotherapy of glioma stem-like cells
============================================================================================================================================================================

* Richard Baugh
* Hena Khalique
* Emma Page
* Janet Lei-Rossmann
* Peter Kok-Ting Wan
* Timothy Johanssen
* Daniel Ebner
* Olaf Ansorge
* Leonard W Seymour